This test is most useful if any of these apply to you.
Two people on the same continent can have wildly different gut bacterial communities, and one of the biggest dividing lines is how much Prevotella they carry. This single genus often defines a person's whole gut ecosystem, shaped by years of eating habits, geography, and a long list of health conditions ranging from rheumatoid arthritis to Parkinson's disease.
Your stool Prevotella reading is a window into that ecosystem. It will not give you a diagnosis on its own, but it can suggest which broad community type you fall into and flag patterns worth tracking alongside diet, inflammation, and any chronic conditions you are managing.
Prevotella is a genus of bacteria, meaning a broad family of single-celled microbes (not a protein, hormone, or chemical your body makes). Most of these bacteria live in the gut and the mouth, and a stool test counts their genetic fingerprint to estimate how many are present in the lower intestine. The most common gut species is Prevotella copri, but other species like P. stercorea can dominate in different people.
Prevotella tends to thrive in people who eat a lot of plant fiber and complex carbohydrates. Many studies describe a Prevotella-dominated gut community type, which scientists call a Prevotella enterotype, that contrasts with a Bacteroides-rich pattern more common in Western diets. In non-Western and Indian cohorts, Prevotella is often the most abundant bacterial group in the gut.
These bacteria specialize in breaking down complex plant fibers and producing short-chain fatty acids (small molecules your gut cells use for energy and inflammation control). Some strains can also nudge the immune system toward inflammatory signaling, which is why their effects on health are not uniformly good or bad.
Prevotella is one of the most paradoxical bacterial groups in the gut. Different species, and even different sub-strains, can carry opposite implications for health. The same elevated reading might reflect a healthy fiber-rich diet in one person and a pattern associated with autoimmune disease in another.
This is not a simple high-is-bad or low-is-good marker. It is a community-pattern indicator, and different patterns carry different risks for different conditions. A Prevotella-rich gut can be protective in the context of plant-based eating and fiber metabolism while also being a feature of immune systems that may be more prone to inflammatory conditions like rheumatoid arthritis. The same number can mean different things depending on the rest of your clinical picture, diet, and symptoms.
Some of the clearest signals tying Prevotella to disease come from rheumatoid arthritis research. People in pre-clinical stages of rheumatoid arthritis, including first-degree relatives of patients, show enrichment of Prevotella copri compared with people not at risk. In one study of individuals at increased risk for rheumatoid arthritis, Prevotella copri levels were elevated before any joint symptoms appeared, suggesting it tracks with immune patterns that precede the disease.
Once rheumatoid arthritis develops, Prevotella copri shows immune relevance: patients can mount antibody and T-cell responses against the bacterium. In a large observational study of patients with rheumatoid arthritis, baseline gut microbiome composition predicted whether people responded to standard arthritis drugs, and several Prevotella species declined in those who improved clinically.
Prevotella overgrowth has also been observed in people with pre-hypertension and hypertension. In a study of about 196 people, those with elevated blood pressure carried a Prevotella-dominated community pattern, which the researchers linked to inflammatory signaling that may help drive the rise in blood pressure.
A systematic review combining multiple cohorts found Prevotella enrichment among the consistent gut signatures of non-alcoholic fatty liver disease. A separate microbial signature study in chronic liver disease patients identified gut patterns that predicted advanced fibrosis (scarring) regardless of the underlying cause.
Prevotella copri has been linked to a higher-risk metabolic gut pattern in some analyses. A study stratifying people by gut community type found that a Prevotella-enriched cluster associated with higher rates of obesity and diabetes. At the same time, in a separate study of about 1,098 deeply phenotyped adults, Prevotella copri tracked with favorable post-meal glucose responses in some contexts, which is part of why context matters more than a single threshold.
Higher stool Prevotella before surgery was associated with better colorectal cancer outcomes in an observational study of colorectal cancer patients. A microbial score that included Prevotella outperformed standard clinical markers like CEA and lymphatic invasion for predicting progression and survival. This is not a screening test for cancer, but it suggests Prevotella patterns may carry prognostic weight once cancer is diagnosed.
Other research highlights that species-level resolution matters: when confounders such as stool consistency are controlled, the connections between specific Prevotella species and colorectal cancer can shift, emphasizing that total Prevotella alone is not a reliable cancer marker.
Lower stool Prevotella has been reported in people with Parkinson's disease across multiple cohorts, and the reduction appears stable over time. In a longitudinal study of Parkinson's patients followed for two years, gut differences including reduced Prevotella persisted and showed some connection to disease progression.
In children, lower fecal Prevotella at 12 months of age was associated with more behavioral difficulties at age two in a study of around 201 infants, and antibiotic exposure was a leading predictor of low Prevotella in early life. Reduced gut Prevotella has also been observed in autism spectrum disorder and multiple sclerosis cohorts, though these are associations, not causal findings.
In a study of rural African children, higher Prevotella stercorea was associated with fewer and shorter infections. In hospitalized patients at risk for Clostridioides difficile infection, lower baseline Prevotella (alongside reduced overall diversity) predicted who would later develop the infection in a multicenter analysis.
This double-edged pattern shows up in athletes too. In a study of cyclists, those with higher Prevotella copri showed larger post-exercise inflammatory responses, with Prevotella copri abundance explaining a meaningful share of the variance in inflammation after prolonged exercise.
Gut microbiome composition is one of the most variable lab readings you can take. Daily intensive sampling in healthy adults found substantial day-to-day swings in most gut bacterial genera, driven by stool moisture, transit time, and recent diet. A single Prevotella read is a snapshot, not a trend.
Tracking this marker over time is far more informative than chasing a single number. A practical cadence is a baseline test, a follow-up in 3 to 6 months if you are making meaningful dietary or lifestyle changes, and at least annual monitoring after that. If you start a new medication that broadly affects gut bacteria (antibiotics, proton pump inhibitors, metformin), retesting in a few months can help you see whether your community structure has shifted.
Because this is a research-stage marker without standardized clinical cutpoints, the value comes from comparing your own trend against your earlier baseline, not against a population reference range.
Several factors can shift a single stool reading in ways that do not reflect your underlying gut ecology:
Because Prevotella's clinical meaning depends on context, an out-of-pattern result is the start of a workup, not the end. If you see a very high or very low reading that does not fit your diet or how you feel, retest in a few weeks to confirm it is not a one-day swing. Then look at the picture alongside other markers.
If your reading runs unusually high and you have joint stiffness or family history of rheumatoid arthritis, consider pairing it with rheumatoid factor and anti-CCP antibody testing and a discussion with a rheumatologist. If it is unusually high and you carry metabolic risk, pair it with fasting insulin, HbA1c, ALT, and a lipid panel to see whether liver and glucose patterns track in the same direction. If it is unusually low and you have constipation, sluggish digestion, or early Parkinson's-like symptoms, a broader microbiome panel and a discussion with a gastroenterologist or neurologist may be appropriate. The marker tells you which questions to ask, not which diagnosis to make.
Evidence-backed interventions that affect your Prevotella Species level
Prevotella Species is best interpreted alongside these tests.
Prevotella Species is included in these pre-built panels.